Co-Authors
This is a "connection" page, showing publications co-authored by Steven Chmura and Jason Bugno.
Connection Strength
0.487
-
Myeloid reprogramming generates myeloid-derived activating cells to potentiate radiotherapy and suppress metastasis. Cancer Cell. 2026 Sep 17.
Score: 0.062
-
Radiotherapy induces YTHDF2 in dendritic cells impairing cross-presentation and T cell function. J Exp Med. 2026 01 05; 223(1).
Score: 0.059
-
Publisher Correction: Radiation-induced amphiregulin drives tumour metastasis. Nature. 2025 Nov; 647(8091):E9.
Score: 0.059
-
Radiation-induced amphiregulin drives tumour metastasis. Nature. 2025 07; 643(8072):810-819.
Score: 0.057
-
YTHDF1 loss in dendritic cells potentiates radiation-induced antitumor immunity via STING-dependent type I IFN production. J Clin Invest. 2024 12 02; 134(23).
Score: 0.055
-
Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites. Clin Cancer Res. 2024 May 01; 30(9):1945-1958.
Score: 0.053
-
Epitranscriptional regulation of TGF-ß pseudoreceptor BAMBI by m6A/YTHDF2 drives extrinsic radioresistance. J Clin Invest. 2023 12 15; 133(24).
Score: 0.051
-
YTHDF2 inhibition potentiates radiotherapy antitumor efficacy. Cancer Cell. 2023 07 10; 41(7):1294-1308.e8.
Score: 0.049
-
Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity. Sci Transl Med. 2021 02 24; 13(582).
Score: 0.042